Globus Maritime Limited (the “Company” or "Globus") (NASDAQ: GLBS), a dry bulk shipping company, announced today that through a wholly owned subsidiary, it has entered into an agreement to sell to an ...
Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...
While Nevro recorded income of around $408 million, Globus Medical's sales at $2.52 billion showed a 60.6% annual rise year ...
For the best UK web hosting you'll want to pick a host with servers in the UK or a CDN point of presence. Plenty of the best web hosting providers have these but you'll also want a host that has ...
Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...
LFS estimates have been weighted to 2022 mid-year population estimates for periods from January to March 2019; headline UK seasonally adjusted series before this have been modelled, but other series ...
Globus Spirits shares zoomed 17 per cent in Monday's trade on BSE, logging an intraday high at Rs 930.9 per share. The buying interest in the stock sparked after the company said the Ministry of ...
Table 1: Total imports of goods fell, while exports rose in November 2024 Monthly UK trade in goods, excluding precious metals, current prices, seasonally adjusted, EU and non-EU After removing the ...
The sanctioned banks include Fidelity Bank, First Bank, Keystone Bank, Union Bank, Globus Bank, Providus Bank, Zenith Bank, UBA, and Sterling Bank. According to a BusinessDay report, the fines would ...
Auchan did not immediately respond to a request for comment. The top 20 further comprises food conglomerates like Nestlé, Mars and Pepsi, along with German retailers Metro and Globus. Chinese ...
Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders ...
BofA analyst Craig Bijou upgraded Globus Medical (GMED) to Neutral from Underperform with a price target of $97, up from $80, after the company preannounced Q4 revenue that was 3% above the Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results